22nd-29th April 2024

PIDetect: Enhancing PID Diagnosis in Low- and Middle-Income Countries

Primary immunodeficiencies (PIDs) are believed to affect around 6 million people worldwide, but 70 to 90% of patients do not have access to proper care. The key factor behind these numbers is a low diagnosis rate, particularly in low- and middle-income countries (LMIC). To address this problem, IPOPI has launched the PIDetect programme, which provides intensive training to selected doctors from LMIC to improve their skills in recognising and diagnosing PIDs. The programme is hosted in a PID reference centre and is aimed both at clinicians and laboratory scientists with an interest in PIDs. It comprises intensive clinical and/or laboratory training tailored to the individual needs and background of each attendee, followed by a local implementation activity whereby the acquired expertise is shared more widely with doctors in the target country.